Share on StockTwits

Citing company sources, the Frankfurter Allgemeine Zeitung newspaper reported on Saturday said, Germany’s Bayer faces its first law suits in the United States over anti-clotting drug Xarelto, one of its top five medicines. A Bayer spokesman declined to comment on the newspaper’s report but said the drug’s safety profile since its launch is consistent with the results of clinical studies that involved more than 75,000 patients. Bayer peer Boehringer Ingelheim last month said it would pay about $650 million to settle U.S. lawsuits that claimed the company’s blockbuster blood thinner, Pradaxa, had caused severe and fatal bleeding in patients.



“Bayer Faces Law Suits In United States Over Xarelto: Paper” is categorized as “us”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.